Yvan Beaussant, MD, MSc
Principal Investigator
A hematologist and palliative care physician-investigator trained in psychedelic-assisted therapies, Dr. Yvan Beaussant’s research focuses on investigating the safety and efficacy of psychedelic-assisted
therapy and defining standards of care across indications and populations of patients with serious
illness. Dr. Beaussant led an international research seminar at the Harvard Radcliffe Institute and
conducted qualitative studies of experts’ perspectives to define priorities and an agenda for psychedelic
research in serious illness care. His team is now investigating psilocybin- and MDMA-assisted therapy
to address depression, adjustment disorder, pain, and existential distress in this population.
Dr. Beaussant's research works: pubmed.ncbi.nlm.nih.gov/?term=Beaussant+Y&cauthor_id=33848208
therapy and defining standards of care across indications and populations of patients with serious
illness. Dr. Beaussant led an international research seminar at the Harvard Radcliffe Institute and
conducted qualitative studies of experts’ perspectives to define priorities and an agenda for psychedelic
research in serious illness care. His team is now investigating psilocybin- and MDMA-assisted therapy
to address depression, adjustment disorder, pain, and existential distress in this population.
Dr. Beaussant's research works: pubmed.ncbi.nlm.nih.gov/?term=Beaussant+Y&cauthor_id=33848208
Contact: [email protected]